Brian Johnston | Vice President, Investor Relations-Gilmartin Group |
Waleed Hassanein | President & Chief Executive Officer |
Stephen Gordon | Chief Financial Officer |
Suraj Kalia | Oppenheimer |
Josh Jennings | Cowen & Company |
Good afternoon, everyone. Thank you for standing by and welcome to the TransMedics Q2 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] And as a reminder, this conference call is being recorded.